Publication | Closed Access

Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model

Parp InhibitorIschemic Stroke ModelCerebrovascular DiseaseCerebral Vascular RegulationThrombosisMatrix Metalloproteinase-9 LevelBrain InjuryNeurologyAtherosclerosisIschemic SyndromeMedicineNeuropharmacologyVascular BiologyCerebral Blood FlowReperfusion InjuryPharmacologyIschemic StrokeStroke-related ConditionNeuroscienceStroke